JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB65621

Protease Inhibitor Cocktail

Be the first to review this product! Submit a review

|

(82 Publications)

Protease inhibitor cocktail is a water-soluble mixture used to inhibit a wide range of proteases during protein extraction, preventing protein degradation.

- Cited in over 25 publications- It is a part of the multiplex kits range- Can be used with a variety of sample types, including mammalian tissue and cell extracts.

Key facts

Product details

Abcam's Protease Inhibitor Cocktail contains a mixture of water-soluble protease inhibitors with broad specificity for various proteases, and has been optimized to generate the maximal protection to mammalian tissue and cell extracts.

Form:
Supplied as a lyophilized powder.
One vial can make 125 ml of cocktail solution.

Preparation:
Add 250 μl DMSO to the vial, pipette several times to dissolve all powder (This makes 500X concentrated inhibitor cocktail).

Visit our FAQs page for tips and troubleshooting.

This product is manufactured by BioVision, an Abcam company and was previously called K271 Protease Inhibitor Cocktail. K271-500 is the same size as the 1 kit size of ab65621.

Crude cell extracts contain many endogeneous enzymes, such as proteases and phosphotases, which can degrade valuable proteins in the extract. The individual components of the protease inhibitor cocktail have specific inhibitory properties. A description of each inhibitor is given below:

Aprotinin: Inhibits serine proteases, such as trypsin, chymotrypsin, plasmin, trypsinogen, urokinase, and kallikrein.

Leupeptin: Inhibits both serine and cysteine proteases, such as calpain, trypsin, papain, and cathepsin B.

Pepstatin A: Inhibits acid proteases, such as pepsin, rennin, cathepsin D, chymosin, and protease B.

PMSF: Inhibits serine proteases, such as trypsin and chymotrypsin. Also inhibits cysteine proteases and mammalian acetylcholinesterase.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab65621-1Kit", "assetComponentDetails": [ { "size":"1 x 1 Vial", "name":"Protease Inhibitor Cocktail I", "number":"AB65621-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Publications (82)

Recent publications for all applications. Explore the full list and refine your search

Cytotechnology 77:137 PubMed40621114

2025

Mechanistic insights into Aloin-mediated regulation of STAT3/SLC7A11 signaling in head and neck squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Jian Wang,Jun Wang

PloS one 20:e0320484 PubMed40131896

2025

Proteomic characterization of clinical Candida glabrata isolates with varying degrees of virulence and resistance to fluconazole.

Applications

Unspecified application

Species

Unspecified reactive species

Pamela El Khoury,Ahmad Zeidan,Roy A Khalaf

Frontiers in cell and developmental biology 13:1550220 PubMed40114965

2025

Lysine lactylation analysis of proteins in the heart of the Kawasaki disease mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Wenyu Zhuo,Mingyang Zhang,Jiajia Tan,Yang Gao,Yan Wang,Nana Wang,Jin Ma,Jiaying Zhang,Zhiheng Liu,Haitao Lv,Ying Liu

Turkish neurosurgery 35:129-140 PubMed39840570

2025

Evaluation of the Effects of HDAC Activity in Hydroxychloroquine Applied Human Primary Chondrocyte and Nucleus Pulposus Cultures.

Applications

Unspecified application

Species

Unspecified reactive species

Yasin Emre Kaya,Numan Karaarslan,Ibrahim Yilmaz,Tamer Tamdogan,Sevim Ondul,Duygu Yasar Sirin,Hanefi Ozbek

Breast cancer research : BCR 26:175 PubMed39623404

2024

NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Payton De La Cruz,Julia McAdams,Melanie Morales Aquino,Aileen I Fernandez,Andrew Elliott,Maryam Lustberg,Christoph Schorl,Jennifer R Ribeiro,Nicole E James

Scandinavian journal of immunology 100:e13414 PubMed39487565

2024

F-Box and WD repeat domain containing 7 induces infectious osteomyelitis by regulating MYB stability and ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Yongbo Wan,Gehan Jiang,Haojie Shan,Yiwei Lin,Wenyang Xia,Fuli Yin,Chaolai Jiang,Zhongmin Shi

Pharmaceuticals (Basel, Switzerland) 17: PubMed39338298

2024

Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines.

Applications

Unspecified application

Species

Unspecified reactive species

Rossana Galassi,Nicola Sargentoni,Sofia Renzi,Lorenzo Luciani,Caterina Bartolacci,Prasad Pattabhi,Cristina Andreani,Stefania Pucciarelli

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2400107 PubMed39234815

2024

FGF12 Positively Regulates Keratinocyte Proliferation by Stabilizing MDM2 and Inhibiting p53 Activity in Psoriasis.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Wang,Xiejun Xu,Fangqian Guan,Yifan Lin,Yizhou Ye,Jie Zhou,Jianjun Feng,Sihang Li,Junbo Ye,Zhouhao Tang,Wenjie Gao,Bohao Sun,Yingjie Shen,Li Sun,Yonghuan Song,Litai Jin,Xiaokun Li,Weitao Cong,Zhongxin Zhu

Frontiers in cellular neuroscience 18:1407975 PubMed39139401

2024

Impaired olfactory performance and anxiety-like behavior in a rat model of multiple sclerosis are associated with enhanced adenosine signaling in the olfactory bulb via AR, AR, and AR.

Applications

Unspecified application

Species

Unspecified reactive species

Andjela Stekic,Milorad Dragic,Jelena Stanojevic,Marina Zaric Kontic,Ivana Stevanovic,Milica Zeljkovic Jovanovic,Katarina Mihajlovic,Nadezda Nedeljkovic

Cancers 16: PubMed39001381

2024

Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Elvis Martinez-Jaramillo,Fatemeh Jamali,Farah H Abdalbari,Bassam Abdulkarim,Bertrand J Jean-Claude,Carlos M Telleria,Siham Sabri
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com